Michele M. Merrette - Bridgewater NJ, US John J. Tsai - Belle Mead NJ, US Paul H. Richardson - Plainsboro NJ, US
Assignee:
National Starch and Chemical Investment Holding Corporation - New Castle DE
International Classification:
D21H 1724
US Classification:
162175, 1062061, 536102, 536106
Abstract:
This invention relates to a degraded, inhibited cationic starch for use in papermaking systems, which affords improved physical properties, particularly strength. Additionally these derivatives provide easy-to-prepare alternatives totraditional starches, and can even be added directly to the papermaking process without cooking. While the benefits of these starch compositions can be applied to any type of papermaking method, they are especially useful in high shear, high conductivity and recycle systems.
Susan Lydzinski - Belle Mead NJ, US Todd Manegold - Somerset NJ, US Daniel Solarek - Hillsborough NJ, US John Tsai - Belle Mead NJ, US Christine Puglisi - Mountainside NJ, US
International Classification:
A61K009/70 A61K007/16 A61K031/718
US Classification:
424/443000, 514/060000
Abstract:
The present invention relates to a film, particularly an oral film, which contains starch as the main component. Such film is useful for delivering a variety of agents to humans and other animals to produce a therapeutic, organoleptic, or cosmetic effect, including breath fresheners, flavors, fragrances and pharmaceuticals.
Susan Lydzinski - Belle Mead NJ, US Todd Manegold - Somerset NJ, US Daniel Solarek - Hillsborough NJ, US John Tsai - Belle Mead NJ, US Christine Puglisi - Mountainside NJ, US
International Classification:
A61K007/16 A61K009/70 A61K031/718
US Classification:
424/443000, 514/060000
Abstract:
The present invention relates to a film, particularly an oral film, which contains starch as the main component. Such film is useful for delivering a variety of agents to humans and other animals to produce a therapeutic, organoleptic, pharmacological, agricultural or cosmetic effect, including breath fresheners, flavors, fragrances and pharmaceuticals.
Method For Thickening Or Stabilizing Aqueous Media With Polyamphoteric Polysaccharides
National Starch and Chemical Investment Holding Corporation - Wilmington DE
International Classification:
D21H 1745 D21H 1724 C09K 702
US Classification:
507121
Abstract:
A method of thickening, stabilizing, controlling mobility, or enhancing water retention in aqueous media and electrolyte-containing aqueous media employs neutrally-charged polyamphoteric graft copolymers of polysaccharides with zwitterionic monomers or cationic/anionic monomer pairs. These polyampholytes are characterized by their unique resistance to loss of intrinsic viscosity in the presence of electrolytes. These polyampholytes may be prepared by an inverse emulsion method of graft copolymerization. One such electrolyte-tolerant polyampholyte is a novel composition prepared by graft copolymerization of guar gum.
Cationic Polysaccharides And Reagents For Their Preparation
John (Ji-Hsiung) Tsai - Belle Mead NJ Peter T. Trzasko - Plainsboro NJ Michael T. Philbin - Plainsboro NJ Robert L. Billmers - Stockton NJ Martin M. Tessler - Edison NJ Joseph A. Van Gompel - Lodi WI Morton W. Rutenberg - No. Plainfield NJ
Assignee:
National Starch and Chemical Investment Holding Corporation - Wilmington DE
International Classification:
D21H 1724
US Classification:
162175
Abstract:
Cationic polysaccharide derivatives are prepared by reacting a polysaccharide with a polycationic reagent having one polysaccharide reactive group and at least two cationic groups. Suitable reagents include polycationic alkyl, aryl, alkaryl, cycloaliphatic, or heterocyclic amines, some of which are novel compositions. The polycationic polysaccharide derivatives prepared from these reagents are useful in the manufacture of paper.
Acetals Useful For The Preparation Of Polysaccharide Derivatives
John J. Tsai - Belle Mead NJ Patrick G. Jobe - Westfield NJ Diane J. Lamb - Lincoln NE Martin M. Tessler - Edison NJ
Assignee:
National Starch and Chemical Investment Holding Corporation - Wilmington DE
International Classification:
C07D30308 C07D30312
US Classification:
549551
Abstract:
Polysaccharide aldehydes having the formula Sacch--O--CH. sub. 2 --CH. dbd. CH--CHO, Saach--O--CH. sub. 2 --C. tbd. C--CHO, ##STR1## starch, cellulose, and gum aldehydes, are useful for imparting wet, dry, or temporary wet strength to paper. They are prepared by a non-oxidative method which involves reacting the polysaccharide base, in the presence of alkali, with a derivatizing acetal reagent having the general structure ##STR2## and then hydrolyzing the acetal by adjusting the pH to less than 7, preferably 2-4. In the formulas, n is 1-3; R. sup. 11 and R. sup. 12 are independently an alkyl, aryl, aralkyl, or alkaryl group when n is 1, R. sup. 11 or R. sup. 12 is one of the groups when n is 2, or R. sup. 11 and R. sup. 12 are not present when n is 3; R. sup. 13 is an alkyl group, optionally containing an ether linkage, or an aralkyl group; R. sup. 14 and R. sup.
Starch Foam Products With Improved Flexibility/Compressibility And The Method Of Preparation Thereof
John Tsai - Belle Mead NJ Christopher L. Kulp - Palmer PA Walter Maliczyszyn - Somerville NJ Paul A. Altieri - Belle Mead NJ David C. Rawlins - Piscataway NJ
Assignee:
National Starch and Chemical Investment Holding Corporation - Wilmington DE
International Classification:
C08L 500 C08J 900
US Classification:
521 841
Abstract:
An expanded shaped product with improved flexural compressibility and surface properties comprising starch and a hydrophobically modified acid anhydride or its acid hydrolyzed counterpart and the method of preparing such product by extrusion.
Polysaccharide Graft Polymers Containing Acetal Groups And Their Conversion To Aldehyde Groups
John J. Tsai - Belle Mead NJ Patrick G. Jobe - Westfield NJ Robert L. Billmers - Stockton NJ
Assignee:
National Starch and Chemical Corporation - Bridgewater NJ
International Classification:
C08B 3108 C08B 3714 D21H 320
US Classification:
527300
Abstract:
Polysaccharide graft polymers which comprise an acetal-containing or aldehyde-containing homopolymer or copolymer grafted to a polysaccharide base have been prepared. The monomer repeating units in the homopolymer are derived from one or more ethylenically or allylically unsaturated monomers containing an acetal group or aldehyde group; The monomer repeating units in the copolymer are derived from the above monomer and derived from one or more ethylenically or allylically unsaturated monomers other than the acetal-containing or aldehyde-containing monomer. A and A' are independently a lower alkyl or A and A' together form at least a 5-membered cyclic acetal; with the proviso that the graft polymer contain no ##STR1## groups when the aldehyde groups are present. The aldehyde-containing graft polymers are useful for imparting wet strength to paper. Various novel acetal- and aldehyde-containing monomers have also been prepared; they can be graft polymerized to polysaccharide substrates or polymerized by conventional emulsion polymerization techniques with vinyl polymerizable monomers.
Dr. Tsai graduated from the Northwestern University Feinberg School of Medicine in 2001. He works in Tucson, AZ and 1 other location and specializes in Gastroenterology. Dr. Tsai is affiliated with Carondelet Saint Josephs Hospital and Cornerstone Hospital Of Southeast Arizona.
Dr. Tsai graduated from the George Washington University School of Medicine and Health Science in 1998. He works in Centreville, VA and 1 other location and specializes in Pediatrics and Adolescent Medicine. Dr. Tsai is affiliated with Inova Fair Oaks Hospital.
Dr. Tsai graduated from the Ohio State University College of Medicine in 1987. He works in Massillon, OH and specializes in Cardiovascular Disease. Dr. Tsai is affiliated with Mercy Medical Center.
Kaiser Permanente Medical GroupKaiser Permanente Anesthesiology 9300 Imperial Hwy, Downey, CA 90242 (562)4613000 (phone), (562)6579953 (fax)
Education:
Medical School Albert Einstein College of Medicine at Yeshiva University Graduated: 1997
Languages:
English
Description:
Dr. Tsai graduated from the Albert Einstein College of Medicine at Yeshiva University in 1997. He works in Downey, CA and specializes in Pediatric Anesthesiology.
nchise and Global Head of Medical Affairs for the Pharmaceuticals business unit. Dr. Aradhye will report to Vas Narasimhan and join the ECN. With the changes in organizational structure and operating model, John Tsai, M.D., has decided to pursue opportunities outside Novartis effective May 15th, 2022.
Date: Apr 04, 2022
Category: Business
Source: Google
Novartis to test hydroxychloroquine for coronavirus
We recognise the importance of answering the scientific question of whether hydroxychloroquine will be beneficial for patients with COVID-19 disease, said John Tsai, head of Global Drug Development and chief medical officer at Novartis. We mobilised quickly to address this question in a randomise